"No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia
- PMID: 38402389
- PMCID: PMC10894474
- DOI: 10.1186/s12954-024-00960-9
"No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia
Abstract
Background: Primary needle and syringe programs (NSPs) have been integral for the prevention of blood-borne virus (BBV) transmission among people who inject drugs. Despite this, many people who inject drugs face barriers accessing these services, particularly after-hours when most services are closed. To our knowledge, the St Kilda NSP, in Melbourne, Victoria, is the only primary NSP providing 24/7 dedicated stand-alone face-to-face services for people who inject drugs in Australia. We conducted an evaluation of the St Kilda NSP to assess its role and effectiveness in meeting client needs.
Methods: Mixed research methods were used to conduct the evaluation. We analysed four quantitative data sets including the Victorian Needle and Syringe Program Information System data; NSP 'snapshot' survey data; and St Kilda NSP records of after-hours contacts and naloxone training events. Qualitative interviews were conducted with 20 purposively selected NSP clients, which were focused on individual needs, expectations and experiences accessing the service. Interviews were audio recorded and transcribed, and data were analysed thematically. A convergent research design was used to merge the five data sets.
Results: St Kilda NSP had 39,898 service contacts in 2018; 72% of contacts occurred outside business hours. Similarly, of 1,185,000 sterile needles and syringes dispatched, 71% were distributed outside business hours. Participants described valuing the after-hours service because drug use patterns did not always align with standard NSP opening hours and after-hours access afforded anonymity when collecting injecting equipment. Narratives highlighted several additional benefits of the 24/7 service, including: access to safer sex equipment; material support; naloxone training; referrals to specialist services; face-to-face emotional and social support from a non-judging worker; and for women involved in sex work in particular, being able to seek refuge when feeling unsafe on the streets.
Conclusions: Our study provides evidence of the social and health benefits (beyond that of preventing BBV transmission) that can be gained through the provision of 24/7 primary NSP services. Findings support the need for the establishment of after-hours primary NSPs in other areas of Australia where active street-based drug markets operate outside business hours and concentrated numbers of people who inject drugs live and spend time.
Keywords: Australia; Blood-borne virus (BBV) prevention; Harm reduction; People who inject drugs; Primary needle and syringe programs (NSPs); Street-based sex work.
© 2024. The Author(s).
Conflict of interest statement
Rebecca Thatcher is employed by The Salvation Army Territory Australia, who funded this study.
Figures
Similar articles
-
Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.Int J Drug Policy. 2021 Oct;96:103387. doi: 10.1016/j.drugpo.2021.103387. Epub 2021 Jul 28. Int J Drug Policy. 2021. PMID: 34330571
-
Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.Drug Alcohol Depend. 2018 Oct 1;191:259-265. doi: 10.1016/j.drugalcdep.2018.07.007. Epub 2018 Aug 22. Drug Alcohol Depend. 2018. PMID: 30153607
-
Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.Int J Drug Policy. 2016 Jan;27:138-45. doi: 10.1016/j.drugpo.2015.08.018. Epub 2015 Sep 3. Int J Drug Policy. 2016. PMID: 26394538
-
Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact.Harm Reduct J. 2018 Feb 8;15(1):6. doi: 10.1186/s12954-018-0212-3. Harm Reduct J. 2018. PMID: 29422042 Free PMC article. Review.
-
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.Addiction. 2018 Mar;113(3):545-563. doi: 10.1111/add.14012. Epub 2017 Oct 23. Addiction. 2018. PMID: 28891267 Free PMC article.
Cited by
-
Discreet but accessible: a qualitative study with people who use drugs and service staff about the optimal design of a harm reduction vending machine in rural Kentucky.Harm Reduct J. 2025 May 28;22(1):88. doi: 10.1186/s12954-025-01222-y. Harm Reduct J. 2025. PMID: 40426237 Free PMC article.
-
Pharmacy-related syringe access barriers: an audit of Oregon community pharmacies.Harm Reduct J. 2025 Mar 20;22(1):37. doi: 10.1186/s12954-025-01190-3. Harm Reduct J. 2025. PMID: 40114161 Free PMC article.
-
The impact of restricted community accessibility on needle and syringe sharing among drug users in Baise city: based on the event study method.BMC Public Health. 2025 Mar 8;25(1):928. doi: 10.1186/s12889-025-22088-6. BMC Public Health. 2025. PMID: 40057708 Free PMC article.
References
-
- Carrotte E, Dietze P, Kirwan A. Syringe coverage and Australian NSPs. Melbourne (AUST): Centre for Research Excellence into Injecting Drug Use; 2015. https://creidu.edu.au/system/policy_document/12/pdf/Policy_Brief_Kirwan_....
-
- O’Keefe D, Ritter A, Stoove M, Hughes C, Dietze P. Harm reduction programs and policy in Australia: barriers and enablers to effective implementation. Sucht. 2020;66(1):33–43. doi: 10.1024/0939-5911/a000641. - DOI
-
- Heard S, Iversen J, Geddes L, Kwon JA, Maher L. Needle syringe program national minimum data collection: 2021 National data report 2021. Sydney (AUST): Kirby Institute; 2021. https://www.kirby.unsw.edu.au/research/projects/ansps.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources